Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Measures of Motor Impairment in Early Parkinson's Disease
A completed clinical trial sponsored by the National Institute of Neurological Disorders and Stroke evaluating measures of motor impairment …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Motor Skill Learning in People With Parkinson's Disease
The NINDS-sponsored clinical trial NCT00396942 assessing motor skill learning in people with Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2017-06-23Clinical Trial Update: MRI Compatible and Long-term LFP Recordable Deep Brain Stimulation on PD Patients [Phase 1]
Phase 1 clinical trial update evaluating MRI-compatible, long-term LFP-recordable deep brain stimulation in Parkinson's disease patients.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Telemedicine Intervention to Improve Physical Function [NA]
A completed clinical trial evaluating a telemedicine program to improve physical function in Parkinson's disease; results were posted in 201…
-
CLINICAL_TRIALS research · 2017-06-22Clinical Trial Update: Wuling Powder for the Treatment and Underlying Mechanism of Depressive Symptoms in Patients With Parkinson's Disease [Phase 4]
Phase 4 clinical trial evaluating Wuling Powder for depressive symptoms in Parkinson's disease. The study also investigates potential underl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease [NA]
Completed clinical trial evaluating real-time functional MRI neurofeedback as a treatment approach for Parkinson's disease.
-
FDA approval · 2017-06-21FDA Approved: AMANTADINE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original ANDA for amantadine, enabling the marketing of a generic version.
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: Combined Stimulation of STN and SNr for Resistant Freezing of Gait in Parkinson's Disease [NA]
Update on a clinical trial evaluating combined stimulation of the subthalamic nucleus and substantia nigra reticulata to treat resistant fre…
-
FDA approval · 2017-06-16FDA Approved: XADAGO — Supplemental Application (MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.)
The FDA approved a supplemental application for XADAGO (safinamide mesylate) filed by MDD US Operations LLC (a subsidiary of Supernus Pharma…
-
FDA approval · 2017-06-12FDA Approved: AMANTADINE HYDROCHLORIDE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's Original Application for amantadine hydrochloride, authorizing the marketing of a generic formulation.
-
FDA approval · 2017-06-09FDA Approved: AMANTADINE HYDROCHLORIDE — Original Application (Strides Pharma Inc.)
FDA approved an Original Application for amantadine hydrochloride by Strides Pharma Inc., granting generic approval for this product.
-
FDA approval · 2017-06-07FDA Approved: AMANTADINE HYDROCHLORIDE — Original Application (Strides Pharma Inc.)
FDA approved the original application for amantadine hydrochloride from Strides Pharma Inc., enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Follow-up Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008AA) [Phase 1]
Phase 1 follow-up study assessing a second booster of AFFITOPE PD01A for safety and preliminary clinical activity in Parkinson's disease; th…
-
FDA approval · 2017-06-05FDA Approved: ENTACAPONE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Entacapone (Macleods Pharmaceuticals Limited) under an Original Application (ANDA) for the U.S. market. Entacapone is used as a…
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Managing Changes in Life After Deep Brain Stimulation for Parkinson's Disease [NA]
This clinical trial update discusses managing changes in life after deep brain stimulation therapy for Parkinson's disease, focusing on adap…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999 [EARLY_Phase 1]
An early-phase 1 trial evaluating a new radiopharmaceutical, [18F] LBT-999, to quantify the dopamine transporter in humans with Parkinson's …
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD) [NA]
Clinical trial update indicating completion of a Deep Brain Stimulation (DBS) study for early-stage Parkinson's disease, with results posted…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers [Phase 2]
Phase 2 trial evaluating the safety, tolerability, and effects of ubiquinol on oxidative damage and mitochondrial biomarkers in Parkinson di…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease
A clinical trial studying dysarthria, swallowing disorders, and respiratory function in Parkinson's disease has completed at University Hosp…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa [Phase 3]
A Phase 3 clinical trial comparing fixed-dose carbidopa/levodopa/entacapone with immediate-release carbidopa/levodopa for Parkinson's diseas…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Cardiovascular Events in Parkinson's Disease Patients
The completed trial update reports on the incidence of cardiovascular events in Parkinson's disease patients and summarizes safety outcomes …
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: Parkinson's Diseases Susceptibility Genes and Pesticides
This update reports on a completed clinical trial examining how Parkinson's disease susceptibility genes may interact with pesticide exposur…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Dopaminergic Modulation of Declarative Memory [Phase 4]
Phase 4 clinical trial on dopaminergic modulation of declarative memory in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Assessment of Three-dimensional Vision Alteration in Parkinson Disease [NA]
A completed clinical trial evaluated three-dimensional vision alterations in individuals with Parkinson disease (NCT01620164) conducted at U…
-
CLINICAL_TRIALS research · 2017-05-12Clinical Trial Update: Education in Therapy of Parkinson's Disease [NA]
Clinical trial update on education in therapy for Parkinson's disease; the study is completed.